Fountain Healthcare Partners — Full Portfolio

Priothera is a clinical-stage biotech developing mocravimod (an S1P receptor modulator) for hematologic malignancies such as acute myeloid leukemia.

BiotechHealthtech

FGFlorent Gros(Chief Executive Officer and Founder)SOStephan Oehen(Chief Operating Officer and Founder)inBrice Suire(Chief Financial Officer and Founder)NCNigel Clark(Chief Business Officer)JHJens Hasskarl(Chief Medical Officer)

Co-investorsHEHealthCap4S4see Ventures

XyloCor Therapeutics develops gene therapies for advanced coronary artery disease and cardiac damage.

BiotechHealthtechMedical DevicesMalvern, US

RCRonald Crystal(Founder and Advisor (Board Observer))TRTodd Rosengart(Founder; Board Observer)JTJohn Tucker(President and CEO)Albert Gianchetti(Executive Officer, Director)

BoardGBGlenn Batchelder(Director)inJames Cohen(Director)

Co-investorsLULumira VenturesJEJeito CapitalLOLongwood FundSOSofinnova Ventures

Amarin Corporation is a cardiovascular health pharmaceutical company developing treatments to prevent cardiovascular disease.

BiotechHealthtechMedical Devices

Co-investorsAVAvoro Capital AdvisorsLOLongitude CapitalSISignet Healthcare PartnersSOSofinnova Ventures

Aneta operates an email-based AI research service that runs 15 specialized agents across academic, market, technical, and legal sources for days to produce long, citation-backed research reports.

AI & Machine LearningEnterprise SoftwareSaaS

Co-investorsPEPebblebedANAndera PartnersBGBGVFOForbionHTHTGFPMPMV+2 more

HealthtechHayward, US

GDGUY DIPIERRO(Director)inALAN LEVY, PH.D.(Executive Officer, Director)ANTHONY RIMAC(Executive Officer)ALAN LEVY(Executive Officer, Director)

BoardELIZABETH ROCKETT(Director)WHWENDE HUTTON(Director)in

Co-investorsCOCota CapitalEMEmergent Medical Partners, LLPKAKaiser Permanente VenturesMIMission Bay Capital5A5AM VenturesCACanaan Partners+2 more

BiotechChelsea, US

RICHARD BATYCKY(Executive Officer)GLENN BATCHELDER(Director)BRYAN STUART(Executive Officer)inMIMARK IWICKI(Executive Officer, Director)inMFMARTIN FREED(Executive Officer)in

BoardRHROB HOPFNER(Director)in

Co-investorsCACanaan PartnersLOLongitude CapitalSOSofinnova VenturesBABay City CapitalOROrbiMedRARA Capital

Exciva is a company focused on neurological and neurodegenerative conditions, led by a team with expertise in chemistry, clinical operations, and regulatory affairs.

BiotechDigital HealthLongevityMedical DevicesHeidelberg, DE

HMHans Moebius(Co-founder and CMO, Head of Clinical Operations)inABAnton Bespalov(Co-founder and CSO, Head of Regulatory Affairs)in

Co-investorsANAndera PartnersCACARMA FUNDGIGimvLBLBBW Venture Capital GmbHLILifeArc VenturesMOModi Ventures

Mainstay provides an AI-powered platform that enables higher education institutions to engage students through proactive, personalized coaching and messaging.

AI & Machine LearningEdTechHR TechSaaSArlington, US

AMAndrew Magliozzi(Founder)inKDKirk Daulerio(Co-Founder, Vice President, Community)in

BoardKEVIN TALBOT(Director)

Co-investorsALAlumni VenturesBIBisk VenturesEAEastward Capital PartnersFUFundersClubK K Street CapitalMIMichelson 20MM Foundation+12 more

Irish company developing an advanced neurostimulation device.

HealthtechPlymouth, US

Dan Sachs(Director)PCPeter Crosby(Executive Officer, Director)inJason Hannonin

BoardMRManus Rogan(Director)inAPAntoine Papiernik(Director)in

Co-investorsIRIreland Strategic Investment FundSESeventure PartnersSOSofinnova PartnersVIViking GlobalALAlly Bridge GroupGIGilde Healthcare+1 more

MMI develops miniaturized robotic surgical instruments and platforms to enable surgeons to perform complex microsurgery and supermicrosurgery on delicate anatomical structures with greater precision.

HealthtechMedical DevicesRoboticsJacksonville, US

MTMark Toland(Executive Officer, Director)inAndrew Cleeland(Director)JLJustin Lynch(Director)inTheresa Jean Cameron(Director)Caleb Moore(Executive Officer)Augusto Vianna Castello(Director)

Co-investorsANAndera PartnersBIBioStar CapitalDEDeerfield Management CompanyFIFidelity InvestmentsRARA CapitalCOCorewell Health Ventures

Neurent Medical develops the NEUROMARK system, a radiofrequency ablation device that targets hyperactive autonomic nerves to treat chronic rhinitis symptoms in ENT patients.

HardwareHealthtechMedical Devices

Co-investorsATAtlantic Bridge VenturesCLClaret Capital PartnersMVMVM Life Science PartnersSOSofinnova PartnersENEnterprise IrelandEQEQT Life Sciences+1 more

Neuromod is a medical technology company that developed Lenire, an FDA-approved bimodal neuromodulation device for treating tinnitus.

HardwareHealthtechMedical Devices

RORoss O'Neill(Founder)in

Co-investorsXBXB Ventures

Spark Therapeutics, now part of the Roche Group, focuses on delivering therapies to improve patient outcomes and create healthier communities.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsSOSofinnova Ventures

AbbVie is a pharmaceutical company that discovers and develops medicines, working with external innovation partners to conduct research.

BiotechHealthtech

Co-investorsARArtis VenturesCOCowles VenturesNENew Enterprise Associates (NEA)WEWestern Technology InvestmentFIFidelity InvestmentsFOFounders Fund

Biotechnology company developing products for overactive bladder and irritable bowel syndrome.

BiotechMalvern, US

Douglas Gessl(Executive Officer)inJames Walker(Executive Officer, Director)in

BoardScott Morenstein(Director)David Hirsch(Director)James Bennethum(Director)Stephen Tullman(Director)

Co-investorsLOLongitude CapitalSASamsara BioCapital

Vivasure Medical develops polymer-based vascular closure devices and delivery systems for structural heart and endovascular interventions.

BiotechHealthtechMedical DevicesGalway, IE

Co-investorsPAPanakes Partners